Immune to Cancer: The CRI Blog
-
What Ever Happened to Coley’s Toxins?
Experts today agree that a 100-year-old therapy cured cancer in some cases. Why did it fall out…
-
How the Oncogene Opened the Door for Targeted Therapy
Episode 2 of The Emperor of All Maladies focused on key 20th century discoveries that changed the…
-
Beyond Magic Bullets: Helen Coley Nauts and the Battle for Immunotherapy
How one woman who lacked a college degree took on the cancer establishment and changed the course…
-
‘Emperor of All Maladies’, Quotes That Make You Think
Three quotes from night one of #CancerFilm that stopped Emily Helck in her tracks.
-
A Run to Reach New Heights
Earlier this month, Team CRI runners ran the 2015 United Airlines Half Marathon in NYC.
-
Whose Cancer Is It, Anyway?
When navigating cancer with someone you love, does the experience belong to just one of you?
-
Merck’s PD-1 Drug Outperforms Ipilimumab for Treatment of Advanced Melanoma
Data from a phase III trial indicate that Keytruda stands ready to become standard-of-care for advanced melanoma.
-
Longboarding in the Fight Against Cancer with James McGary
Professional longboarder James is going the distance: he's longboarding from Seattle to New York City to raise…
-
Pam G’s Immunotherapy Story
Lung Cancer | Diagnosed 2013 I would not be alive today if it were not for this…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.